Home
About
Overview
Sharing Data
ORCID
Help
History (3)
A multicenter, phase II study of bortezomib (PS-341) in patients with unresectable or metastatic gastric and gastroesophageal junction adenocarcinoma.
Cancer and Leukemia Group B
The Shifting Paradigm for Breast Cancer Surgery in Patients Undergoing Neoadjuvant Chemotherapy.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The Shifting Paradigm for Breast Cancer Surgery in Patients Undergoing Neoadjuvant Chemotherapy.
The Shifting Paradigm for Breast Cancer Surgery in Patients Undergoing Neoadjuvant Chemotherapy. Ann Surg Oncol. 2018 Jan; 25(1):164-172.
View in:
PubMed
subject areas
Adult
Aged
Breast Neoplasms
Chemotherapy, Adjuvant
Decision Making
Female
Humans
Mastectomy
Mastectomy, Segmental
Middle Aged
Neoadjuvant Therapy
Neoplasm Staging
Patient Preference
Prophylactic Mastectomy
Retrospective Studies
authors with profiles
Katharine Yao